An act amending the act of December 14, 1992 (P.L.1116, No.145), entitled "An act providing minimum standards, terms and conditions for the licensing of persons who engage in wholesale distributions in interstate commerce of prescription drugs; and making a repeal," further providing for definitions and for license application.
Referred to Health
Email me when SB 1206 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 1206. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill adds a new definition for "virtual manufacturer"—a Pennsylvania‑based entity that markets drugs or medical devices without ever holding the physical product in the state. It changes the license application to require only a statement that the company has applied or will apply for FDA approval, and bars the department from demanding FDA approval as a licensing condition. The changes become law 60 days after enactment.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 1206
3 free questions a day, no accountHearings
- AppropriationsSenate Appropriations · Jun 21, 2026
- Institutional Sustainability & InnovationSenate Institutional Sustainability & Innovation · Jun 9, 2026
Sponsors
- Tracy Pennycuick (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 1206 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1206 freeOr ask your AI assistant about SB 1206 directly:
Add to Claude, ChatGPT or Cursor